Clinical significance of BRAF/NRAS concurrent mutations in a clinic‐based metastatic melanoma cohort. (1st May 2020) - del Regno, L.; Louveau, B.; Battistella, M.; Sadoux, A.; Baroudjian, B.; Delyon, J.; Serror, K.; Allayous, C.; Lebbe, C.; Mourah, S.; Jouenne, F.